Abstract
Black cumin, Nigella sativa (NS), which is also known as black seed (Kalijeera), is an annual flowering plant from the Ranunculaceae family. Its seeds were used in most ancient medical systems. For ages it was considered to be a panacea. It is rooted in our traditions and has flourished into an intensively investigated medicinal plant. There is an abundance of reports on the biological activities of Nigella sativa seeds or extracts. The spectrum of its activity is impressive and includes antimicrobial, antiviral, anticancer, antimalarial as well as an antidiabetic or immunostimulatory potency. In this review both in vitro and in vivo results are gathered and the results of clinical trials are discussed. Patents and the industrial use of NS as both a food supplement and as animal feed are also mentioned. An analysis of the literature data showed that the comprehensive investigations of Nigella sativa are fairly well translated into actual everyday healthcare. The data presented in this review reveals future use of this valuable plant.
Keywords: Anticancer, antimicrobial, gastroprotective, Nigella sativa, thymoquinone.
Graphical Abstract
The Natural Products Journal
Title:Nigella sativa – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare
Volume: 6 Issue: 1
Author(s): Anna Mrozek-Wilczkiewicz and Robert Musiol
Affiliation:
Keywords: Anticancer, antimicrobial, gastroprotective, Nigella sativa, thymoquinone.
Abstract: Black cumin, Nigella sativa (NS), which is also known as black seed (Kalijeera), is an annual flowering plant from the Ranunculaceae family. Its seeds were used in most ancient medical systems. For ages it was considered to be a panacea. It is rooted in our traditions and has flourished into an intensively investigated medicinal plant. There is an abundance of reports on the biological activities of Nigella sativa seeds or extracts. The spectrum of its activity is impressive and includes antimicrobial, antiviral, anticancer, antimalarial as well as an antidiabetic or immunostimulatory potency. In this review both in vitro and in vivo results are gathered and the results of clinical trials are discussed. Patents and the industrial use of NS as both a food supplement and as animal feed are also mentioned. An analysis of the literature data showed that the comprehensive investigations of Nigella sativa are fairly well translated into actual everyday healthcare. The data presented in this review reveals future use of this valuable plant.
Export Options
About this article
Cite this article as:
Mrozek-Wilczkiewicz Anna and Musiol Robert, Nigella sativa – A Functional Spice From A Pharaoh’s Tomb to Modern Healthcare, The Natural Products Journal 2016; 6 (1) . https://dx.doi.org/10.2174/2210315506999151209100649
DOI https://dx.doi.org/10.2174/2210315506999151209100649 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design, Synthesis and Biological Evaluation of a Phenyl Butyric Acid Derivative, N-(4-chlorophenyl)-4-phenylbutanamide: A HDAC6 Inhibitor with Anti-proliferative Activity on Cervix Cancer and Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Class II Phosphoinositide 3-Kinases as Potential Novel Drug Targets
Current Signal Transduction Therapy Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets Pentapeptides as Minimal Functional Units in Cell Biology and Immunology
Current Protein & Peptide Science Bioinformatics Analysis of Functional Relations Between CNPs Regions
Current Bioinformatics Inorganic Nanomedicines and their Labeling for Biological Imaging
Current Topics in Medicinal Chemistry Unknown Primary Squamous Cell Carcinoma of the Head and Neck
Current Cancer Therapy Reviews E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers
Current Cancer Drug Targets Ipilimumab and Vemurafenib: Two Different Routes for Targeting Melanoma
Current Cancer Drug Targets Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia
Current Drug Targets Compartmentalized Platforms for Neuro-Pharmacological Research
Current Neuropharmacology Immunotherapeutic Options for Pediatric Malignancies
Current Immunology Reviews (Discontinued) Bioproducts from Seaweeds: A Review with Special Focus on the Iberian Peninsula
Current Organic Chemistry Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature
Current Medicinal Chemistry Sunitinib in the Treatment of Thyroid Cancer
Current Medicinal Chemistry Berberine Interfered with Breast Cancer Cells Metabolism, Balancing Energy Homeostasis
Anti-Cancer Agents in Medicinal Chemistry Multimodality Imaging of RNA Interference
Current Medicinal Chemistry Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?
CNS & Neurological Disorders - Drug Targets Is Senescence Reversible?
Current Drug Targets